Brainstem tumors

Brain and Spinal Tumors of Childhood

Volumn , Issue , 2004, Pages 291-313

  Walker, David ^a   Punt, Jonathan A G ^a   Sokal, Michael ^b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84983573258     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (106)

1. Stiller CA, Nectoux J. International Incidence of Childhood Brain and Spinal Tumours. Int J Epidemiol 1994; 23:458-64.
2. Cartmill M, Punt J. Brain stem gliomas, the role of biopsy. Br J Neurosurg 1997; 11:177.
3. Steck J, Friedman W. Stereotactic biopsy of brainstem mass lesions. Surg Neurol 1995; 43:563-7.
4. Sun B, Wang C, Wang J. MRI characteristics of midbrain tumours. Neuroradiology 1999; 41:158-62.
5. Hamilton M, Lauryssen C, Hagen N. Focal midbrain glioma: Long term survival in a cohort of 16 patients and the implications for management. Can J Neurol Sci 1996; 23:204-7.
6. Squires L, Allen J, Abbott R, Epstein F. Focal tectal tumors: Management and prognosis. Neurology 1994; 44:953-6.
7. Grant R, Naylor B, Junck L, Greenberg HS. Clinical outcome in aggressively treated meningeal gliomatosis. Neurology 1992; 42:252-4.
8. Hoffman HJ. Dorsally exophytic brain stem tumors and midbrain tumors. Pediatr Neurosurg 1996; 24:256-62.
9. Felice KJ, DiMario FJ. Cervicomedullary astrocytoma simulating a neuromuscular disorder. Pediatr Neurol 1999; 20:78-80.
10. Abbott R, Shiminski-Maher T, Epstein F. Intrinsic tumors of the medulla: Predicting outcome after surgery. Pediatr Neurosurg 1996; 25:41-4.
11. Teo J, Goh K, Rosenblum M, Muszynski C, Epstein F. Intraparenchymal clear cell meningioma of the brainstem in a 2-year-old child. Case report and literature review. Pediatr Neurosurg 1998; 28:27-30.
12. Behnke J, Christen H, Mursch K, Markakis E. Intra-axial enophytic tumors in the pons and/or medulla oblongata II. Intraoperative findings, postoperative results, and 2-year follow up in 25 children. Childs Nerv Syst 1997; 13:135-46.
13. Constantini S, Miller D, Allen J, Rorke L, Freed D, Epstein F. Radical excision of intramedullary spinal cord tumors: Surgical morbidity and long-term follow-up evaluation in 164 children and young adults. J Neurosurg 2000; 92 (2 suppl.):183-93.
14. Poussaint T, Yousuf N, Barnes P, et al. Cervicomedullary astrocytomas of childhood: Clinical and imaging follow-up. Pediatr Radiol 1999; 29:662-8.
15. Robertson PL, Allen JC, Abbott IR, Miller DC, Fidel J, Epstein FJ. Cervicomedullary tumors in children: A distinct subset of brainstem gliomas. Neurology 1994; 44:1798-803.
16. Galbraith JG, Sahni P. Diagnosis of brainstem tumours. Hosp Med 1970; 6:134-41.
17. Sarkari NBS, Bickerstaff ER. Relapses and remissions in brain stem tumours. Br Med J 1969; 2:21-3.
18. Stroink AR, Hoffman HJ, Hendrick EB, Humphreys RP. Diagnosis and management of pediatric brain-stem gliomas. J Neurosurg 1986; 65:745-50.
19. Barkovich AJ, Krischer J, Kun LE, etal. Brain stem gliomas: A classification system based on magnetic resonance imaging. Pediatr Neurosurg 1990; 16:73-83.
20. Fischbein NJ, Prados MD, Wara W, Russo C, Edwards MSB, Barkovich AJ. Radiologic classification of brain stem tumors: Correlation of magnetic resonance imaging appearance and clinical outcome. Pediatr Neurosurg 1996; 24:9-23.
21. Edgeworth J, Bullock P, Bailey A, Gallagher A, Crouchman M. Why are brain tumours still being missed? Arch Dis Child1996; 74:148-51.
22. Saha V, Love S, Eden T, Mitchell-Eynaud P, McKinlay G. Determinants of symptom interval childhood cancer. Arch Dis Child 1993; 68:771-4.
23. Pollock B, Krischer JP, Vietti TJ. Interval between symptom onset and diagnosis of pediatric solid tumors. J Pediatr 1991; 119:725-32.
24. Flores LE, Williams DL, Bell BA, O'Brien M, Ragab A. Delay in diagnosis of pediatric brain tumors. Am J Dis Child 1986; 140:684-6.
25. Hughes R. Neurological Complications of Neurofibromatosis 1. London: Chapman & Hall, 1994.
26. Molloy P, Bilaniuk L, Vaughan S, et al. Brainstem tumors in patients with neurofibromatosis type 1: A distinct clinical entity. Neurology 1995; 45:1897-902.
27. Raffel C, McComb JG, Bodner S, Gilles FE. Benign brain stem lesions in pediatric patients with neurofibromatosis: Case reports. Neurosurgery 1989; 25:959.
28. Broniscer A, Gajjar A, Bhargava R, et al. Brain stem involvement in children with neurofibromatosis type 1: Role of magnetic resonance imaging and spectroscopy in the distinction from diffuse pontine glioma. Neurosurgery 1997; 40:331 -8.
29. Milstein JM, Geyer R, Berger MS, Bleyer W. Favourable prognosis for brainstem gliomas in neurofibromatosis. J Neuro-Oncol 1989; 7:367.
30. Pollack IF, Shultz B, Mulvihill JJ. The management of brainstem gliomas in patients with neurofibromatosis 1. Neurology 1996; 46:1652-60.
31. Lingam S. Right from the Start. The Way Parents are Told that Their Child has a Disability. London: British Paediatric Association [now Royal College of Paediatrics & Child Health], 1996.
32. Walker DA, Hockley A, Taylor R, et al. Guidance for Services for Children and Young People with Brain and Spinal Tumours. London: Royal College of Paediatrics and Child Health, 1997.
33. Duffner PK, Cohen ME, Flannery JT. Referral patterns of childhood brain tumors in the State of Connecticut. Cancer1982; 50:1636-40.
34. Weissman DE. Glucocorticoid treatment for brain metastases and epidural spinal cord compression: A review. J Clin Oncol1988; 6:543-51.
35. Glaser AW, Buxton N, Hewitt M, Punt J, Walker DA. The role of steroids in paediatric central nervous system malignancies. Br J Neurosurg 1996; 10:123-4.
36. MacArthur D. The role of neuroendoscopy in the management of brain tumours. Br J Neurosurg 2002; 16:465-70.
37. Punt J. Principles of CSF diversion and alternative treatments. In: Schurr P, Polkey C (eds). Hydrocephalus. Oxford: Oxford Medical Publications, 1993, pp. 139-60.
38. Chapman PH. Indolent gliomas of the mid-brain tectum. In: Marlin A (ed.). Concepts in Pediatric Neurosurgery. Basel: Karger, 1989, pp. 97-107.
39. Pollack IF, Pang D, Albright AL. The long-term outcome in children with late onset aqueduct stenosis resulting from benign intrinsic tectal tumors. J Neurosurg 1994; 80:681-8.
40. Calaminus G, Bamberg M, Baranzelli MC, et al. Intracranial germ cell tumors: A comprehensive update of the European data. Neuropediatrics 1994; 25:26.
41. Epstein F, Constantini S. Practical decisions in the treatment of pediatric brain stem tumors. Pediatr Neurosurg 1996; 24:24-34.
42. Albright AL, Wisoff JH, Zeltzer PM, et al. Effects of medulloblastoma resections on outcome in children: A report from the Children's Cancer Group. Neurosurgery 1996; 38:265-71.
43. Bruggers CS, Friedman HS, Fuller GN, et al. Comparison of serial PET and MRI scans in a pediatric patient with a brainstem glioma. Med Pediatr Oncol 1993; 21:301 -306.
44. Nadvi SS, Ebrahim ES, Corr P. The value of 201 thallium-SPECT imaging in childhood brainstem gliomas. Pediatr Radiol 1998; 28:575-9.
45. Maria BL, Drane WB, Quisling RJ, Hoang KBN. Correlation between gadolinium-diethylene-triaminepentaacetic acid contrast enhancement and thallium-201 chloride uptake in pediatric brainstem glioma. J Child Neurol 1997; 12:341-8.
46. Morota N, Deletis V, Epstein F, et al. Brain stem mapping: Neurophysiological localisation of motor nuclei on the floor of the fourth ventricle. Neurosurgery 1995; 37:922-30.
47. Molloy P, Yachnis A, Rorke L, et al. Central nervous system medulloepithelioma: A series of eight cases including two arising from the pons. J Neurosurg 1996; 84:430-6.
48. Epstein F. Intra-axial tumors of the cervico-medullary junction in children. Concept Pediatr Neurosurg 1987; 7:117.
49. Freeman C, Farmer J-P. Pediatric brain stem gliomas: A review. Int J Radiat Oncol Biol Phys 1998; 40:265-71.
50. Jenkin R, Boesel C, Ertel I, et al. Brain-stem tumors in childhood: A prospective randomized trial of irradiation with and without adjuvant CCNU, VCR, and prednisone. J Neurosurg 1987; 66:227-33.
51. Packer RJ, Boyett JM, Zimmerman RA, et al. Hyperfractionated radiation therapy (72 Gy) for children with brain stem gliomas. Cancer 1993; 72:1414-21.
52. Freeman C, Krischer J, Sanford R, et al. Final results of a study of escalating doses of hyperfractionated radiotherapy in brain stem tumors in children: A Pediatric Oncology Group study. Int J Radiat Oncol Biol Phys 1993; 27:197-206.
53. Lewis J, Lucraft H, Gholkar A. UKCCSG study of accelerated radiotherapy for pediatric brain stem glioma. Int J Radiat Oncol Biol Phys 1997; 38:925-9.
54. Lee F. Radiation of infratentorial and supratentorial brainstem tumors. J Neurosurg 1975; 43:65-8.
55. Halperin EC, Wehn SM, Scott JW, et al. Selection of a management strategy for pediatric brainstem tumors. Med Pediatr Oncol 1989; 17:116-25.
56. Albright AL, Guthkelch AN, Packer RJ, et al. Prognostic factors in pediatric brainstem gliomas. J Neurosurg 1986; 65:751-5.
57. Freeman C, Kepner J, Kun L, et al. A detrimental effect of a combined chemotherapy-radiotherapy approach in children with diffuse intrinsic brain stem gliomas? Int J Radiat Oncol Biol Phys 2000; 47:561-4.
58. Freeman C, Krischer J, Sanford R, Burger P, Cohen M, Norris DG. Hyperfractionated radiotherapy in brain stem tumors: Results of a Pediatric Oncology Group study. Int J Radiat Oncol Biol Phys 1988; 15:311-18.
59. Freeman C, Krischer J, Sanford R, et al. Hyperfractionated radiation therapy in brain stem tumors. Cancer 1991; 68:474-81.
60. Packer RJ, Littman PA, Sposto RM, et al. Results of hyperfractionated radiation therapy for children with brainstem gliomas. Int J Radiat Oncol Biol Phys 1987; 13:1647-51.
61. Packer R, Boyett JM, Zimmerman R, et al. Outcome of children with brain stem gliomas after treatment with 7800 cGy of hyperfractionated radiotherapy. A Children's Cancer Group phase I/II trial. Cancer 1994; 74:1827-34.
62. Mandell L, Kadota R, Freeman C, et al. There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: Results of a pediatric oncology group phase III trial comparing conventional vs hyperfractionated radiotherapy. Int J Radiat Oncol Biol Phys 1999; 43:959-64.
63. Edwards MSB, Wara WM, Urtasun RC, et al. Hyperfractionated radiation therapy for brain-stem glioma: A phase I-II trial. J Neurosurg 1989; 70:691-700.
64. Freeman C, Bourgouin P, Sanford R, et al. Long term survivors of childhood brain stem gliomas treated with hyperfractionated radiotherapy. Clinical characteristics and treatment related toxicities. The Pediatric Oncology Group. Cancer 1996; 77:555-62.
65. Sonoda Y, Kumabe T, Takahashi T, et al. Clinical usefulness of 11C-MET PET and 201Tl SPECT for differentiation of recurrent glioma from radiation necrosis. Neurol Med Chir (Tokyo) 1998; 38:342-8.
66. Birch J, Marsden HB, Morris Jones PH, Pearson D, Blair V. Improvements in survival from childhood cancer: Results of a population-based survey over 30 years. Br Med J 1988; 296:1372-6.
67. Draper GJ, Birch JM, Bithell JF, et al. Childhood cancer in Britain - incidence, survival and mortality. In: Studies on Medical and Population Subjects, report no. 37. London: Hmso, 1982.
68. Stevens MC, Cameron AH, Muir KR, Parkes SE, Reid H, Whitwell H. Descriptive epidemiology of primary central nervous system tumours in children: A population-based study. Clin Oncol 1991; 3:323-9.
69. Packer RJ, Zimmerman RA, Kaplan A, et al. Early cystic/necrotic changes after hyperfractionated radiation therapy in children with brain stem gliomas. Cancer 1993; 71:2666-74.
70. Mulhern RK, Heideman RL, Khatib Z. Quality of survival among children treated for brain stem glioma. Pediatr Neurosurg1994; 20:226-32.
71. Mandigers CMPW, Lippens RJJ, Hoogenhout J, Meijer E, v Wieringen PMV, Theeuwes AGM. Astrocytoma in childhood: Survival and performance. Pediatr Hem Oncol1990; 7:121-8.
72. Mundinger F, Braus DF, Krauss JK, Birg W. Long-term outcome of 89 low-grade brain-stem gliomas after interstitial radiation therapy. J Neurosurg 1991; 75:740-6.
73. Morota N, Deletis V, Lee M, Epstein F. Functional anatomic relationship between brain-stem tumors and cranial motor nuclei. Neurosurgery 1996; 39:787-93.
74. Allen J, Packer RJ, Bleyer A, Zeltzer P, Prados M, Nirenberg A. Recombinant interferon beta: A phase I-II trial in children with recurrent brain tumors. J Clin Oncol 1991; 9:783-8.
75. Estlin E, Lashford LS, Ablett S, et al. Phase I study of temozolomide in paediatric patients with advanced cancer. Br J Cancer 1998; 78:652-61.
76. Ettinger L, Ru N, Krailo M, Ruccione KS, Krivit W, Hammond GD. A phase II study of diaziquone in children with recurrent or progressive primary brain tumors: A report from the Children's Cancer Study Group. J Neuro-Oncol 1990; 9:69-76.
77. Gaynon PS, Ettinger LJ, Baum ES, Siegel SE, Krailo MD, Hammond GD. Carboplatin in childhood brain tumors. A Children's Cancer Study Group phase II trial. Cancer 1990; 66:2465-9.
78. Friedman H, Krischer JP, Burger P, et al. Treatment of children with progressive or recurrent brain tumors with carboplatin or iproplatin: A Paediatric Oncology Group randomized phase II study. J Clin Oncol 1992; 10:249-56.
79. Allen JC, Walker R, Luks E, Jennings M, Barfoot S, Tan C. Carboplatin and recurrent childhood brain tumors. J Clin Oncol 1987; 5:459-63.
80. Zeltzer PM, Epport K, Nelson MD, Jr, Huff K, Gaynon P. Prolonged response to carboplatin in an infant with brain stem glioma. Cancer 1991; 67:43-7.
81. Walker RW, Allen JC. Cisplatin in the treatment of recurrent childhood primary brain tumors. J Clin Oncol 1988; 6:62-6.
82. Sexauer CL, Khan A, Berger PC, et al. Cisplatin in recurrent pediatric brain tumors: A POG phase II study. Cancer 1985; 56:1497-501.
83. Diez B, Monges J, Sackmann Muriel F. Evaluation of cisplatin in children with recurrent brain tumors. Cancer Treat Rep1985; 69:911-13.
84. Needle MN, Molloy PT, Geyer JR, et al. Phase II study of daily oral etoposide in children with recurrent brain tumors and other solid tumors. Med Pediatr Oncol 1997; 29:28-32.
85. Chamberlain MC. Recurrent brainstem gliomas treated with oral VP-16. J Neuro-Oncol 1993; 15:133-9.
86. Arndt CAS, Krailo MD, Steinherz L, Scheithauer B, Liu-Mares W, Reaman GH. A phase II clinical trial of idarubicin administered to children with relapsed brain tumors. Cancer1998; 83:813-16.
87. Heideman RL, Douglass EC, Langston JA, et al. A phase II study of every other day high dose ifosfamide in pediatric brain tumors: A Pediatric Oncology Group Study. J Neuro-Oncol 1995; 25:77-84.
88. Allen JC, Walker R, Rosen G. Preradiation high-dose intravenous methotrexate with leucovorin rescue for untreated primary childhood brain tumors. J Clin Oncol 1988; 6:649-53.
89. Allen JC, Hancock C, Walker R, Tan C. PCNU and recurrent childhood brain tumors. J Neuro-Oncol 1987; 5:241-4.
90. Heideman RL, Packer RJ, Reaman GH, et al. A phase II evaluation of thiotepa in pediatric central nervous system malignancies. Cancer 1993; 72:271 -5.
91. Razzouk BI, Heideman RL, Friedman HS, et al. A phase II evaluation of thiotepa followed by other multi-agent regimens in infants and young children with malignant brain tumors. Cancer 1995; 75:2762-7.
92. Blaney SM, Phillips PC, Packer RJ, etal. Phase II evaluation of topotecan for pediatric central nervous system tumors. Cancer 1996; 78:527-31.
93. Chastagner P, Olive D, Philip T, et al. Efficacy of the”8 drugs in 1 day" regimen for the treatment of brain tumors in children. Arch Fr Pediatr 1988; 45:249-54.
94. Van Eys J, Baram TZ, Cangir A, Bruner JM, Martinez-Prieto J. Salvage chemotherapy for recurrent primary brain tumors in children. J Pediatr 1988; 113:601 -6.
95. Corden BJ, Strauss LC, Killmond T, et al. Cisplatin, ara-C and etoposide (PAE) in the treatment of recurrent childhood brain tumors. J Neuro-Oncol 1991; 11:57-63.
96. Bouffet E, Mottolese C, Jouvet A, et al. Etoposide and thiotepa followed by ABMT (autologous bone marrow transplantation) in children and young adults with high-grade gliomas. Eur J Cancer 1997; 33:91-5.
97. Dunkel IJ, Garvin JH, Jr, Goldman S, et al. High dose chemotherapy with autologous bone marrow rescue for children with diffuse pontine brain stem tumors. J Neuro-Oncol 1998; 37:67-73.
98. Finlay JL, Goldman S, Wong MC, et al. Pilot study of highdose thiotepa and etoposide with autologous bone marrow rescue in children and young adults with recurrent CNS tumors. J Clin Oncol 1996; 14:2495-503.
99. Ilveskoski I, Saarinen UM, Perkkio M, et al. Chemotherapy with the”8 in 1" protocol for malignant brain tumors in children: A population-based study in Finland. Pediatr Hematol Oncol 1996; 13:69-80.
100. Bouffet E, Raquin M, Doz F, et al. Radiotherapy followed by high dose busulfan and thiotepa. Cancer 2000; 88:685-92.
101. Broniscer A, da Costa Leite C, Lanchote VL, Machado TMS, Cristofani LM, Brainstem Glioma Co-operative Group. Radiation therapy and high-dose tamoxifen in the treatment of patients with diffuse brainstem gliomas: Results of a Brazilian co-operative study. J Clin Oncol 2000; 18:1246-53.
102. Kretschmar CS, Tarbell NJ, Barnes PD, Krischer JP, Burger PC, Kun L. Pre-irradiation chemotherapy and hyperfractionated radiation therapy 66 Gy for children with brain stem tumors. Cancer 1993; 72:1404-13.
103. Allen J, Siffert J, Donahue B, et al. A phase I/II study of carboplatin combined with hyperfractionated radiotherapy for brain stem gliomas. Cancer 1999; 86:1064-9.
104. Jakacki R, Siffert J, Jamison C, Velasquez L, Allen J. Dose-intensive, time-compressed procarbazine, CCNU, vincristine (PCV) with peripheral blood stem cell support and concurrent radiation in patients with newly diagnosed high-grade gliomas. J Neuro-Oncol 1999; 44:77-83.
105. Walter AW, Gajjar A, Ochs JS, et al. Carboplatin and etoposide with hyperfractionated radiotherapy in children with newly diagnosed diffuse pontine gliomas: A phase I/II study. Med Pediatr Oncol 1998; 30:28-33.
106. Doz F, Neuenschwander S, Bouffet E, et al. Carboplatin before and during radiation therapy for the treatment of malignant brain stem tumors: A study by the Societe Francaise d'Oncologie Pediatrique. Eur J Cancer 2002; 38:815-19.